4LPB

Crystal structure of a topoisomerase ATPase inhibitor

Summary for 4LPB

Entry DOI	10.2210/pdb4lpb/pdb
Related	4LP0
Descriptor	Topoisomerase IV subunit B, 1-ethyl-3-{5'-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-3,3'-bipyridin-6-yl}urea (3 entities in total)
Functional Keywords	protein-inhibitor complex, atp binding, structure-based drug design, antimicrobial, virtual screen, atp binding domain, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor
Biological source	Streptococcus pneumoniae
Total number of polymer chains	1
Total formula weight	25078.14
Authors	Boriack-Sjodin, A. (deposition date: 2013-07-15, release date: 2013-10-30, Last modification date: 2024-02-28)
Primary citation	Basarab, G.S.,Manchester, J.I.,Bist, S.,Boriack-Sjodin, P.A.,Dangel, B.,Illingworth, R.,Sherer, B.A.,Sriram, S.,Uria-Nickelsen, M.,Eakin, A.E. Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents. J.Med.Chem., 56:8712-8735, 2013 Cited by PubMed: 24098982 DOI: 10.1021/jm401208b PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.75 Å)

Structure validation